Thor Medical ASA
SWB:8NN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Thor Medical ASA
SWB:8NN
|
NO |
|
Sonoran Desert Copper Corp
XTSX:BEM
|
CA |
|
Largo SA
F:2XH
|
FR |
|
Schwaelbchen Molkerei Jakob Berz AG
F:SMB
|
DE |
|
Leapfrog Acquisition Corp
NASDAQ:LFAC
|
US |
|
F
|
First Tracks Biotherapeutics Inc
NASDAQ:TRAXV
|
US |
|
R
|
Rank Group PLC
XMUN:RNKA
|
UK |
|
A
|
Azbil Corp
XBER:YMK
|
JP |
|
Richmond Minerals Inc
F:R520
|
CA |
|
Z
|
Zenith Minerals Ltd
F:ZCB
|
AU |
|
I
|
Image Pakistan Ltd
KAR:IMAGE
|
PK |
|
Prairie Provident Resources Inc
OTC:PRPRD
|
CA |
|
A
|
Atlanticus Holdings Corp
XBER:YCC
|
US |
|
Color Star Technology Co Ltd
NASDAQ:ADD
|
US |
|
N
|
NH Special Purpose Acquisition 32 Co
KOSDAQ:0054V0
|
KR |
|
S
|
Solowin Holdings Ltd
NASDAQ:SWIN
|
HK |
Wall St Price Targets
8NN Price Targets Summary
Thor Medical ASA
According to Wall Street analysts, the average 1-year price target for 8NN is 0.262 EUR with a low forecast of 0.213 EUR and a high forecast of 0.317 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8NN's stock price target?
Price Target
0.262
EUR
According to Wall Street analysts, the average 1-year price target for 8NN is 0.262 EUR with a low forecast of 0.213 EUR and a high forecast of 0.317 EUR.
What is the Revenue forecast for Thor Medical ASA?
Projected CAGR
714%
Over the last 12 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 714%.